Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthcare Sector Analysis

UpdatedJul 09, 2025
DataAggregated Company Financials
Companies1403
  • 7D-0.9%
  • 3M-1.0%
  • 1Y-7.7%
  • YTD-3.7%

Last week, the Healthcare industry hasn't moved much but Vertex Pharmaceuticals is up 3.1% in that time. Unfortunately though, the industry is down 7.7% over the past 12 months. As for the next few years, earnings are expected to grow by 16% per annum.

Sector Valuation and Performance

Has the U.S. Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 09 Jul 2025US$5.5tUS$3.0tUS$127.9b24.2x42.9x1.8x
Fri, 06 Jun 2025US$5.4tUS$3.0tUS$127.2b23.4x42.8x1.8x
Sun, 04 May 2025US$5.6tUS$2.7tUS$126.2b24.8x44.1x2x
Tue, 01 Apr 2025US$5.6tUS$2.6tUS$81.9b26.3x69x2.1x
Thu, 27 Feb 2025US$5.9tUS$2.6tUS$79.6b25.5x73.7x2.2x
Sat, 25 Jan 2025US$6.0tUS$2.9tUS$85.5b27.9x70.7x2.1x
Mon, 23 Dec 2024US$5.8tUS$2.9tUS$78.2b27.7x73.5x2x
Wed, 20 Nov 2024US$5.9tUS$2.9tUS$76.7b27.1x77.3x2x
Fri, 18 Oct 2024US$6.2tUS$2.8tUS$58.6b31.2x106.6x2.2x
Sun, 15 Sep 2024US$6.3tUS$2.8tUS$60.0b30.6x105.4x2.2x
Tue, 13 Aug 2024US$6.0tUS$2.8tUS$55.3b30.1x108.9x2.1x
Thu, 11 Jul 2024US$6.2tUS$2.8tUS$62.2b30x99x2.2x
Sat, 08 Jun 2024US$6.2tUS$2.8tUS$63.7b30x97.5x2.2x
Mon, 06 May 2024US$6.0tUS$2.8tUS$65.2b31.1x92.6x2.1x
Wed, 03 Apr 2024US$6.3tUS$2.8tUS$84.0b32.5x74.9x2.3x
Fri, 01 Mar 2024US$6.3tUS$2.8tUS$84.2b30.9x74.6x2.3x
Sun, 28 Jan 2024US$6.3tUS$2.8tUS$90.7b32x69.7x2.2x
Tue, 26 Dec 2023US$6.2tUS$2.8tUS$91.5b33.1x67.4x2.2x
Thu, 23 Nov 2023US$5.8tUS$2.8tUS$91.2b28x63.5x2.1x
Sat, 21 Oct 2023US$5.7tUS$2.8tUS$99.6b25.6x57.7x2.1x
Mon, 18 Sep 2023US$6.0tUS$2.8tUS$98.6b29.3x61x2.2x
Wed, 16 Aug 2023US$6.2tUS$2.8tUS$99.4b29x62.3x2.2x
Fri, 14 Jul 2023US$5.9tUS$2.7tUS$110.5b26.3x53.4x2.2x
Sun, 11 Jun 2023US$6.0tUS$2.7tUS$110.4b25.2x53.9x2.2x
Tue, 09 May 2023US$6.0tUS$2.7tUS$111.2b24.9x54.2x2.2x
Thu, 06 Apr 2023US$5.9tUS$2.5tUS$121.8b24.2x48.4x2.4x
Sat, 04 Mar 2023US$5.8tUS$2.5tUS$122.5b25.3x47.3x2.3x
Mon, 30 Jan 2023US$6.0tUS$2.5tUS$133.9b23.8x44.6x2.4x
Wed, 28 Dec 2022US$6.0tUS$2.4tUS$135.7b22.9x44.1x2.4x
Fri, 25 Nov 2022US$6.0tUS$2.4tUS$133.7b24x44.9x2.5x
Sun, 23 Oct 2022US$5.7tUS$2.4tUS$156.7b21.6x36.1x2.3x
Tue, 20 Sep 2022US$5.7tUS$2.4tUS$156.2b22.2x36.7x2.4x
Thu, 18 Aug 2022US$6.1tUS$2.4tUS$157.1b24x38.6x2.5x
Sat, 16 Jul 2022US$5.8tUS$2.6tUS$164.6b24.9x35.3x2.3x
Price to Earnings Ratio

35.3x


Total Market Cap: US$5.8tTotal Earnings: US$164.6bTotal Revenue: US$2.6tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Sector Price to Earnings3Y Average 64.4x202320242025
Current Industry PE
  • Investors are pessimistic on the American Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 42.9x which is lower than its 3-year average PE of 64.4x.
  • The 3-year average PS ratio of 2.2x is higher than the industry's current PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 8.1% per year over the last three years.
  • Meanwhile revenues for these companies have grown 5.5% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare sector?

US Market0.39%
Healthcare-0.93%
Biotech2.10%
Life Sciences0.47%
Pharma0.30%
Healthtech-0.14%
Medical Equipment-1.50%
Healthcare Services-6.38%
Industry PE
  • Investors are most optimistic about the Life Sciences industry, which is trading close to its 3-year average PE ratio of 61.6x.
    • Analysts are expecting annual earnings growth of 16.5%, which is higher than its past year's earnings decline of 6.1% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 23% over the next 5 years.
  • This is roughly in line with its past earnings growth rate.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
VRTX Vertex PharmaceuticalsUS$466.363.1%
+US$3.6b		-4.0%PS10.8x
AMGN AmgenUS$297.002.2%
+US$3.5b		-6.0%PE26.9x
PFE PfizerUS$25.622.3%
+US$3.3b		-7.6%PE18.5x
RGC Regencell Bioscience HoldingsUS$19.3132.3%
+US$2.3b		20,986.3%PB1421.9x
TMO Thermo Fisher ScientificUS$426.171.1%
+US$1.8b		-19.9%PE24.7x

Latest News

ABT
US$133.36
Abbott Laboratories
7D
-2.1%
1Y
31.2%
VRTX
US$466.36
Vertex Pharmaceuticals
7D
3.1%
1Y
-4.0%
MOH
US$231.02
Molina Healthcare
7D
-24.6%
1Y
-19.6%

Molina Healthcare, Inc. (NYSE:MOH) Screens Well But There Might Be A Catch

Jul 08
Molina Healthcare, Inc. (NYSE:MOH) Screens Well But There Might Be A Catch
CNC
US$32.60
Centene
7D
-42.5%
1Y
-50.4%
BSX
US$102.41
Boston Scientific
7D
-2.3%
1Y
33.9%
TMO
US$426.17
Thermo Fisher Scientific
7D
1.1%
1Y
-19.9%
RGC
US$19.31
Regencell Bioscience Holdings
7D
32.3%
1Y
20,986.3%
ELV
US$349.46
Elevance Health
7D
-11.7%
1Y
-34.0%
REGN
US$547.75
Regeneron Pharmaceuticals
7D
2.4%
1Y
-48.0%
ISRG
US$527.30
Intuitive Surgical
7D
-2.0%
1Y
19.2%
AMGN
US$297.00
Amgen
7D
2.2%
1Y
-6.0%
UNH
US$307.70
UnitedHealth Group
7D
-5.7%
1Y
-37.5%
MRNA
US$32.54
Moderna
7D
13.4%
1Y
-72.0%
PFE
US$25.62
Pfizer
7D
2.3%
1Y
-7.6%
LLY
US$777.66
Eli Lilly
7D
0.2%
1Y
-16.6%
CI
US$312.00
Cigna Group
7D
-6.7%
1Y
-5.0%

These 4 Measures Indicate That Cigna Group (NYSE:CI) Is Using Debt Reasonably Well

Jun 19
These 4 Measures Indicate That Cigna Group (NYSE:CI) Is Using Debt Reasonably Well